Evidence map›Paper›PMID 27260505›Full record

ArticleJournal of cardiovascular translational research2016

A Novel Intra-aortic Device Designed for Coronary Blood Flow Amplification in Unrevascularizable Patients.

Udi Nussinovitch, Giorgi Shtenberg, Ariel Roguin, Yair Feld

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cardiovascular translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Coronary artery disease multivessel not amenable to revascularization: contemporary cohort].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Udi NussinovitchDepartment of Internal Medicine A, Rambam Health Care Campus, Ruth and Bruce Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel. enussi@yahoo.com.
Giorgi ShtenbergCorAssist Cardiovascular Ltd, Haifa, Israel.
Ariel RoguinDepartment of Cardiology, Rambam Health Care Campus, Ruth and Bruce Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.
Yair FeldCorAssist Cardiovascular Ltd, Haifa, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with unrevascularizable coronary artery disease represent a substantial number of all patients with coronary disease. However, their therapeutic options are limited; they endure recurrent hospitalizations, a poor quality of life and prognosis. We aim to investigate a novel alternative approach to the treatment of this common medical condition by using a specialized intra-aortic device with coiling properties capable of enhancing diastolic coronary flow. Both a mathematical analysis and in vitro study presented in the current study have yielded enhanced coronary diastolic blood flow and energetic advantages. We suggest that this original approach might be implicated in severely symptomatic unrevascularizable patients.

Indexed as

Coronary CirculationHemodynamicsStentsAortaArterial PressureBlood Flow VelocityCoronary Artery DiseaseEndovascular ProceduresEnergy TransferHumansModels, CardiovascularPolyethyleneProsthesis DesignRegional Blood FlowSeverity of Illness IndexStainless SteelPolyethyleneStainless SteelAngina pectorisCoronary artery diseaseDiastolic flowIntra-aortic deviceIschemic heart diseaseUnrevascularizable

Identifiers

PMID27260505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.